Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.
D000224:Addison Disease / Q000628:therapy; D000307:Adrenal Gland Diseases / Q000628:therapy*; D000310:Adrenal Gland Neoplasms / Q000628:therapy; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010049:Ovarian Diseases / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy; D010673:Pheochromocytoma / Q000628:therapy; D010900:Pituitary Diseases / Q000628:therapy*; D010911:Pituitary Neoplasms / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy; D011388:Prolactin / Q000378:metabolism; D013798:Thecoma / Q000628:therapy
D001971:Bromocriptine; D011388:Prolactin